“My mom is a breast cancer survivor,” said Shellie Javier, editorial director at IMS. “So when I had the chance to write content for the dilon.com site, I took a strong personal interest.”

Dilon Diagnostics is an innovative leader in the medical diagnostics field, and promotes Breast-Specific Gamma Imaging (BSGI) as the new standard of care in breast cancer detection. The Dilon 6800^® Gamma Camera is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers.

“Throughout the site we use multiple messages to speak to medical professionals, hospital administrators, media and patients. The site is a great tool to educate audiences about BSGI through video, flash animations, patient stories, journal studies and more.

“I am thrilled that I was able to help Dilon tell its story. I hope this site encourages more physicians to perform BSGI after a questionable mammogram to detect breast cancer earlier,” said Shellie.